Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anna Citko is active.

Publication


Featured researches published by Anna Citko.


Prenatal Diagnosis | 2014

Potential first trimester metabolomic biomarkers of abnormal birth weight in healthy pregnancies

Michal Ciborowski; Monika Zbucka-Kretowska; Dorota Bomba-Opoń; Miroslaw Wielgos; Robert Brawura-Biskupski-Samaha; Piotr Pierzynski; Maciej Szmitkowski; Slawomir Wolczynski; Danuta Lipinska; Anna Citko; Witold Bauer; Maria Gorska; Adam Kretowski

Macrosomia and low birth weight (LBW) can be associated with pregnancy complications and may affect the long‐term health of the child. The aim of this study was to evaluate the metabolomic serum profiles of healthy pregnant women to identify early biomarkers of macrosomia and LBW and to understand mechanisms leading to abnormal fetal growth not related to mothers body mass index or presence of gestational diabetes.


Gynecological Endocrinology | 2012

The expression of suppressor of cytokine signaling 1 and 3 in fat and placental tissue from women with gestational diabetes

Mariusz Kuzmicki; Beata Telejko; Natalia Wawrusiewicz-Kurylonek; Anna Citko; Danuta Lipinska; Justyna Pliszka; Katarzyna Kalejta; Adam Lemancewicz; Marek Grabiec; Anna M. Pryszczepko-Wawreszuk; Justyna Skibicka; Adam Kretowski; Maria Gorska; Jacek Szamatowicz

The suppressor of cytokine signaling (SOCS) proteins are feedback inhibitors of signaling pathways induced by cytokines, hormones and growth factors. In the present study we measured the expression of SOCS1, SOCS3, interleukin-6 (IL-6), IL-6 receptor, IL-8 and leptin mRNA in paired samples of subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) and placental tissue obtained from 18 pregnant women with normal glucose tolerance (NGT) and 20 subjects with gestational diabetes mellitus (GDM), using quantitative RT-PCR. The patients with GDM had significantly higher IL-8 mRNA expression in VAT than the women with NGT (p = 0.007), whereas the expression of SOCS1, SOCS3 and other genes study did not differ significantly between the two groups. Stepwise regression analysis revealed that SOCS1 mRNA expression in VAT was significantly associated with prepregnancy BMI (β = −0.68, p = 0.03) and IL-8 mRNA expression (β = 0.66, p = 0.03), whereas SOCS3 mRNA expression in VAT was independently predicted by IL-6 mRNA expression (β = 0.94, p = 0.0002, R2 = 0.88). In conclusion, our results did not show significant differences in SOCS1 and SOCS3 mRNA expression in adipose and placental tissue obtained from pregnant women with and without GDM.


Electrophoresis | 2015

CE-MS-based serum fingerprinting to track evolution of type 2 diabetes mellitus.

Michal Ciborowski; Edyta Adamska; Magdalena Rusak; Joanna Godzien; Anna Citko; Witold Bauer; Maria Gorska; Adam Kretowski

Development of type 2 diabetes mellitus (T2DM) is preceded by insulin resistance (IR), which may evolve to impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT). IFG and IGT are considered as prediabetic states (PD). Prediabetes indicates the high risk for the future development of diabetes, it is estimated that up to 70% of prediabetics eventually develop T2DM. The risk of T2DM development is increased in overweight (OW) and obese (OB) people; however normal weight (NW) individuals also suffer from T2DM. The present study was designed to evaluate whether changes in polar metabolites induced by T2DM evolution are different between NW, overweight and obese individuals. CE‐MS serum fingerprinting was performed on 197 serum samples obtained from OW, OB, and NW humans whom were IR, prediabetics, diabetics or with normal glucose homeostasis. Metabolic changes evoked by the progression of T2DM differ between obese, overweight, and normal weight subjects. Based on obtained results several metabolites can be proposed as a promising target to track T2DM evolution; BCAA in OW and NW humans, lysine in OB, while acetylcarnitine and methionine independently on body mass index. Validation of obtained results on larger population is required.


Journal of Maternal-fetal & Neonatal Medicine | 2018

First-trimester irisin and fetuin-A concentration in predicting macrosomia

Monika Zbucka-Kretowska; Mariusz Kuzmicki; Beata Telejko; Joanna Goscik; Michal Ciborowski; Danuta Lipinska; Justyna Hryniewicka; Anna Citko; Slawomir Lawicki; Slawomir Wolczynski

Abstract Objective: We investigated the diagnostic value of first-trimester adipokines and placental markers in predicting macrosomia. Methods: Out of 328 women recruited during the prenatal diagnosis between 11th and 13th week of pregnancy and subjected to follow up until delivery, we selected 26 women who gave birth to macrosomic babies and 34 women who gave birth to normal weight neonates for the evaluation of first trimester serum levels of pregnancy associated plasma protein-A, free β-human chorionic gonadotropin, placental growth factor (PIGF), and selected adipokines. Results: The mothers of macrosomic infants had higher PIGF (p = .049) and irisin concentrations (p = .00003), and lower fetuin-A levels (p = .0002) than had the mothers of normal weight babies. Newborn’s weight correlated positively with maternal irisin (R = 0.454, p = .0003) and negatively with fetuin-A concentrations (R = −0.497, p = .00005). Multiple regression analysis showed that only serum irisin concentration was a significant predictor of birth weight (β = 0.329, p = .03), explaining 14% of its variability. The sensitivity and the specificity of irisin concentration in predicting macrosomia were 0.769 and 0.794, respectively (AUC = 0.818 [95%CI: 0.708–0.928], p = .00001) with a proposed cut-off value of 1725.4 ng/ml. Conclusions: Our results suggest that mother’s irisin may be an early biomarker of macrosomia.


BioMed Research International | 2018

Sedentary Lifestyle and Nonspecific Low Back Pain in Medical Personnel in North-East Poland

Anna Citko; Stanisław Górski; Ludmiła Marcinowicz; Anna Górska

Introduction The sedentary lifestyle is defined as prolonged sitting both at work and during leisure time, with energy expenditures of below 600 MET · min/week. The sedentary lifestyle is a well-known predictor of obesity and other components of the metabolic syndrome. The influence of the sedentary lifestyle and associated factors on nsLBP is still being discussed. Aim The aim of this study was to assess the influence of a sedentary lifestyle and its associated metabolic predictors on the prevalence of nsLBP in nurses and paramedics. Materials and Methods The study included 609 participants, aged 30-60 years, who were residents of north-east Poland. Data was collected using a questionnaire (based, in part, on the Nordic Musculoskeletal Questionnaire), and included details of sociodemographic profile, chronic illnesses, and a short version of the International Physical Activity Questionnaire (IPAQ). Results Nearly half (49.59%) of the respondents reported decreased physical activity, and in the group with recurring nsLBP this figure was 67.59%. Univariate logistic regression modelling found that leading a sedentary lifestyle caused a 3.5-fold increase in the incidence of recurring nsLBP (p<0.001). Excessive coffee consumption significantly increased the likelihood of recurring LBP (OR=16.44, 95% CI: 8.55-31.61), and cigarette smoking increased the likelihood of both recurrent and chronic LBP. The likelihood of chronic low back pain was significantly increased by components of metabolic syndrome such as high blood pressure (over 9-fold), type 2 diabetes (over 3-fold), and hyperlipidemia (over 2-fold) (p<0.001, p<0.001, and p<0.01, respectively). Conclusions A sedentary lifestyle significantly increased the incidence of recurring low back pain, while increased physical activity had a significant effect on the presence of chronic low back pain. In the sedentary lifestyle group, conditions classified within metabolic syndrome were found to significantly increase the chances of developing nonspecific low back pain.


Genes and Nutrition | 2015

The rs340874 PROX1 type 2 diabetes mellitus risk variant is associated with visceral fat accumulation and alterations in postprandial glucose and lipid metabolism

Adam Kretowski; Edyta Adamska; Katarzyna Maliszewska; Natalia Wawrusiewicz-Kurylonek; Anna Citko; Joanna Goscik; Witold Bauer; Anna Golonko; Magdalena Waszczeniuk; Danuta Lipinska; Justyna Hryniewicka; Magdalena Niemira; Magdalena Paczkowska; Michal Ciborowski; Maria Gorska


Advances in Medical Sciences | 2012

The usefulness of glycated hemoglobin A1c (HbA1c) for identifying dysglycemic states in individuals without previously diagnosed diabetes

Edyta Adamska; Magdalena Waszczeniuk; Joanna Gościk; Anna Golonko; Justyna Pliszka; Katarzyna Maliszewska; Danuta Lipinska; Robert Milewski; Anna Wasilewska; Anna Citko; Agnieszka Nikolajuk; Lucyna Ostrowska; Adam Kretowski; Maria Gorska


Roczniki Państwowego Zakładu Higieny | 2012

Differences in dietary habits and food preferences of adults depending on the age

Edyta Adamska; Lucyna Ostrowska; Katarzyna Maliszewska; Anna Citko; Magdalena Waszczeniuk; W Przystupa; R Majewski; Anna Wasilewska; Robert Milewski; Krytowski A; Maria Gorska


Family Medicine & Primary Care Review | 2017

Analysis of risk factors of recurring non-specific low back pain with particular emphasis on “new” predictive factors

Anna Citko; Stanisław Górski; Ludmiła Marcinowicz; Anna Górska


Diabetes & Metabolism | 2017

The type 2 diabetes susceptibility TCF7L2 gene variants affect postprandial glucose and fat utilization in non-diabetic subjects

Edyta Adamska; Adam Kretowski; Joanna Goscik; Anna Citko; Witold Bauer; Magdalena Waszczeniuk; Katarzyna Maliszewska; M. Paczkowska-Abdulsalam; Magdalena Niemira; L. Szczerbinski; Michal Ciborowski; Maria Gorska

Collaboration


Dive into the Anna Citko's collaboration.

Top Co-Authors

Avatar

Maria Gorska

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Adam Kretowski

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Edyta Adamska

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Michal Ciborowski

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Katarzyna Maliszewska

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Magdalena Waszczeniuk

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Danuta Lipinska

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Joanna Goscik

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Witold Bauer

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge